October 2019 FDA Recall Drug by New Vitalis Pharmacy Llc Dba New Vitalis Pharmacy
D-0523-2020 - Lack of sterility assurance.
This Class II drug recall was voluntarily initiated by New Vitalis Pharmacy Llc Dba New Vitalis Pharmacy on October 1, 2019 for the product Drug. The FDA reported the reason for recall as lack of sterility assurance.. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0523-2020
Lack of sterility assurance.
10-01-2019
12-04-2019
2981.62 mL
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
New Vitalis Pharmacy LLC dba New Vitalis Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Distributed Nationwide in the USA
03-09-2023
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection Solution, 10 mL per vial, New Vitalis Pharmacy
Batch or Lot Expiration Information
Lot# Lot, expiry: AL-07232019@99, exp 9-23-2019; AL-07312019@99, exp 9-30-2019; AL-08132019@99, exp 10-13-2019; AL-08272019@901, exp 10-27-2019; AL-08282019@909, exp 10-28-2019; Al-09032019@903, exp 11-3-2019